Shukra Pharmaceuticals Limited

SHUKRAPHAR

Quarterly results

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore
    Quarter₹ croreYoY
    Sept 202644—
  • ₹ crore
    Quarter₹ crore
    Sept 20260.57
  • ₹ crore
    Quarter₹ crore
    Sept 202645
  • Cost structure
  • ₹ crore
    Quarter₹ crore
    Sept 20261
  • ₹ crore
    Quarter₹ crore
    Sept 202624
  • Exceptional items and tax
  • ₹ crore
    Quarter₹ crore
    Sept 202621
  • ₹ crore
    Quarter₹ crore
    Sept 20265
  • Profit
  • ₹ crore
    Quarter₹ croreYoY
    Sept 202616—
  • Per share
  • ₹ per share
    Quarter₹ per share
    Sept 20260.36
₹ croreSept 2026
Income
44
Revenue YoY—
0.57
45
Cost structure
1
24
Exceptional items and tax
21
5
Profit
16
Net profit YoY—
Per share
0.36

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 1 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.